These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21757718)

  • 21. Fibrinogen naples I (B beta A68T) nonsubstrate thrombin-binding capacities.
    Meh DA; Mosesson MW; Siebenlist KR; Simpson-Haidaris PJ; Brennan SO; DiOrio JP; Thompson K; Di Minno G
    Thromb Res; 2001 Jul; 103(1):63-73. PubMed ID: 11434947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of fibrin(ogen) with fibronectin: further characterization and localization of the fibronectin-binding site.
    Makogonenko E; Tsurupa G; Ingham K; Medved L
    Biochemistry; 2002 Jun; 41(25):7907-13. PubMed ID: 12069579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of the thrombin binding sites on fibrin.
    Meh DA; Siebenlist KR; Mosesson MW
    J Biol Chem; 1996 Sep; 271(38):23121-5. PubMed ID: 8798504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II.
    Sabo TM; Farrell DH; Maurer MC
    Biochemistry; 2006 Jun; 45(24):7434-45. PubMed ID: 16768439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
    Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
    Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.
    Cooper AV; Standeven KF; Ariëns RA
    Blood; 2003 Jul; 102(2):535-40. PubMed ID: 12663453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
    Mosesson MW
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein.
    Kluszynski BA; Kim C; Faulk WP
    J Biol Chem; 1997 May; 272(21):13541-7. PubMed ID: 9153200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zn
    Sobczak AIS; Ajjan RA; Stewart AJ
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of thrombin in complex with fibrinogen gamma' peptide.
    Pineda AO; Chen ZW; Marino F; Mathews FS; Mosesson MW; Di Cera E
    Biophys Chem; 2007 Feb; 125(2-3):556-9. PubMed ID: 16962697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
    Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
    J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical modeling to understand the role of bivalent thrombin-fibrin binding during polymerization.
    Kelley MA; Leiderman K
    PLoS Comput Biol; 2022 Sep; 18(9):e1010414. PubMed ID: 36107837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.
    Siebenlist KR; Mosesson MW; Hernandez I; Bush LA; Di Cera E; Shainoff JR; Di Orio JP; Stojanovic L
    Blood; 2005 Oct; 106(8):2730-6. PubMed ID: 16002430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.
    Fredenburgh JC; Leslie BA; Stafford AR; Lim T; Chan HH; Weitz JI
    J Biol Chem; 2013 Oct; 288(41):29394-402. PubMed ID: 23990470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of gamma' chain impairs fibrin polymerization.
    Gersh KC; Nagaswami C; Weisel JW; Lord ST
    Thromb Res; 2009 Jul; 124(3):356-63. PubMed ID: 19138790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing.
    Domingues MM; Macrae FL; Duval C; McPherson HR; Bridge KI; Ajjan RA; Ridger VC; Connell SD; Philippou H; Ariëns RA
    Blood; 2016 Jan; 127(4):487-95. PubMed ID: 26608329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K; Terasawa F; Okumura N
    Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
    Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
    Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.